Health Catalyst Reports Fourth Quarter and Year End 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- Wall Street ends higher as tech rebounds before Nvidia results
- Oil settles down more than 3%; investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Grand Canyon Education places CFO on leave amid stock trade probe
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Six Flags to move headquarters from Charlotte to Arlington, Texas
- Funds sell $44bn in semiconductors on AI concerns
Health Catalyst (HCAT) Tops Q4 EPS by 8c, Revenues Beat; Offers Q1 & FY20 Revenue Guidance
February 27, 2020 5:01 PM ESTHealth Catalyst (NASDAQ: HCAT) reported Q4 EPS of ($0.21), $0.08 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $43.5 million versus the consensus estimate of $41.71 million.
We concluded an exceptional year for Health Catalyst on a high note in the fourth quarter of 2019, achieving strong results across all... More
